The global demand for Lurasidone Market is presumed to reach the market size of nearly USD XX MN by 2028 from USD XX MN in 2021 with a CAGR of XX% under the study period 2022 - 2028.
Lurasidone is atypical antipsychotics medication used to treat schizophrenia and depressive episode associated with bipolar disorder. It functions by changing the activity of certain substances in the brain. It is available under the brand names: Atlura, Lurace, Lurafic, Alsiva, and Emsidon, among others. Lurasidone tablets are available with dosage forms of 20mg, 40mg, 60mg, 80mg, and 120mg.
The rising incidence of schizophrenia and bipolar depression is steering demand for lurasidone. Schizophrenia is a chronic and severe mental disorder affecting 20 million people worldwide. Globally, the prevalence rate of bipolar disorder is 0.3–1.5%. Meanwhile, this prevalence is foreseen to be increasing with rising stress, genes and family history, history of abuse, chemical imbalances in the brain, and a traumatic brain injury. Rising grants by the FDA for lurasidone to treat other health disorders are estimated to create ample market opportunities. However, low awareness about schizophrenia and bipolar depression treatment, lack of specialist practitioners, and approvals in limited geographies hinder the growth of the market.
The research report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of lurasidone. The growth and trends of lurasidone industry provide a holistic approach to this study.
This section of the lurasidone market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.
This section covers the regional outlook, which accentuates current and future demand for the Lurasidone market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.
Global Lurasidone Market Share by Region (Representative Graph)
The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the lurasidone market include Lupin, Sumitomo Dainippon Pharma, Latuda, Hindawi, BioMed. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.
In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.
1 . PREFACE
1.1. Report Description
1.1.2. Target Audience
1.1.3. Unique Selling Proposition (USP) & offerings
1.2. Research Scope
1.3. Research Methodology
1.3.1. Market Research Process
1.3.2. Market Research Methodology
2 . EXECUTIVE SUMMARY
2.1. Highlights of Market
2.2. Global Market Snapshot
3 . LURASIDONE – INDUSTRY ANALYSIS
3.1. Introduction - Market Dynamics
3.2. Market Drivers
3.3. Market Restraints
3.5. Industry Trends
3.6. Porter's Five Force Analysis
3.7. Market Attractiveness Analysis
3.7.1 By Application
3.7.2 By Region
4 . VALUE CHAIN ANALYSIS
4.1. Value Chain Analysis
4.2. Raw Material Analysis
4.2.1. List of Raw Materials
4.2.2. Raw Material Manufactures List
4.2.3. Price Trend of Key Raw Materials
4.3. List of Potential Buyers
4.4. Marketing Channel
4.4.1. Direct Marketing
4.4.2. Indirect Marketing
4.4.3. Marketing Channel Development Trend
5 . IMPACT ANALYSIS OF COVID-19 OUTBREAK
5.1. Impact Analysis of Covid-19 Outbreak
5.1.1. Direct Impact on Production
5.1.2. Supply Chain and Market Disruption
5.1.3. Financial Impact on Firms and Financial Markets
5.2. COVID-19 Impact Analysis by Production, Import, Export and Demand
5.3. Market: Pre V/S Post COVID-19
5.4. Estimated Impact of the Coronavirus (COVID-19) Epidemic
5.5. COVID-19: Micro and Macro Factor Analysis